The World Health Organisation (WHO) on Friday advised against the use of Gilead’s Remdesivir saying that it is not to be used for the treatment of Covid-19 patients no matter how ill they are. A WHO panel said that there is no evidence to suggest that the drug improves survival or reduces the need for ventilation.